CCND1 and breast carcinoma: One of the predicted targets, CCND1 (Fig. 5B), has already been validated as a target of miR-503 and the repression of CCND1 by miR-503 has been reported to inhibit proliferation in breast cancer cell lines (Long et al. 2015).